Willfact ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
288	Autoimmune acquired coagulation factor deficiency	3

288. Autoimmune acquired coagulation factor deficiency

---

Clinical trials : 206 /  Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03613584 (ClinicalTrials.gov)	April 16, 2018	22/3/2018	Von Willebrand Factor Concentrate During ECMO Support	A Double-blind, Placebo-controlled Pilot Trial to Investigate the Administration of Von Willebrand Factor Concentrate (Willfact®, LFB France) in Adult Patients During Extracorporeal Membrane Oxygenation	Acquired Von Willebrand Disease	Drug: Von Willebrand Factor;Drug: Saline Solution	Tirol Kiniken GmbH	LFB BIOMEDICAMENTS	Active, not recruiting	18 Years	N/A	All	68	Phase 2	Austria
2	EUCTR2017-003036-37-AT (EUCTR)	27/10/2017	14/09/2017	The influence of the medication Willfact on the blood loss of patient during the use of a heart-lung machine	A double-blind, placebo-controlled pilot trial to investigate the administration of von Willebrand factor concentrate (Willfact®, LFB France) in adult patients during extracorporeal membrane oxygenation - Von Willebrand factor concentrate during ECMO support	Von Willebrand Disease (VWD) MedDRA version: 20.0;Level: PT;Classification code 10069495;Term: Acquired Von Willebrand's disease;System Organ Class: 10005329 - Blood and lymphatic system disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]	Trade Name: Willfact Product Name: Willfact INN or Proposed INN: von Willebrand Faktor Other descriptive name: VON WILLEBRAND FACTOR Trade Name: Physiologische Kochsalzlösung Fresenius - Infusionslösung Product Name: Physiologische Kochsalzlösung Fresenius - Infusionslösung INN or Proposed INN: Natriumchlorid 0,9 % Other descriptive name: SODIUM CHLORIDE SOLUTION 0.9% Trade Name: Willfact Product Name: Willfact INN or Proposed INN: von Willebrand Faktor Other descriptive name: VON WILLEBRAND FACTOR Trade Name: Willfact Product Name: Willfact INN or Proposed INN: von Willebrand Faktor Other descriptive name: VON WILLEBRAND FACTOR	Tirol Kliniken GmbH	NULL	Not Recruiting			Female: yes Male: yes	68	Phase 2	Austria
3	EUCTR2016-000789-53-AT (EUCTR)	09/03/2017	17/10/2016	The influence of the medication Willfact on the blood loss of patient during the use of a heart-lung machine	A pilot trial to investigate the administration of von Willebrand factor concentrate (Willfact®, LFB France) in adult patients during extracorporeal membrane oxygenation - Willfact during ECMO	Von Willebrand Disease (VWD) MedDRA version: 19.1;Level: PT;Classification code 10069495;Term: Acquired Von Willebrand's disease;System Organ Class: 10005329 - Blood and lymphatic system disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]	Trade Name: Willfact Product Name: Willfact INN or Proposed INN: von Willebrand Faktor Other descriptive name: VON WILLEBRAND FACTOR Trade Name: Physiologische Kochsalzlösung Fresenius - Infusionslösung Product Name: Physiologische Kochsalzlösung Fresenius - Infusionslösung INN or Proposed INN: Natriumchlorid 0,9 % Other descriptive name: SODIUM CHLORIDE SOLUTION 0.9% Trade Name: Willfact Product Name: Willfact INN or Proposed INN: von Willebrand Faktor Other descriptive name: VON WILLEBRAND FACTOR Trade Name: Willfact Product Name: Willfact INN or Proposed INN: von Willebrand Faktor Other descriptive name: VON WILLEBRAND FACTOR	Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Austria